Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American Respiratory Labs, often branded as ARL or ARL Respiratory Labs, is an independent, privately owned provider of advanced diagnostic respiratory services, specializing in mobile pulmonary function testing (spirometry, DLCO), oximetry, sleep studies, and staff/caregiver training. Its key therapeutic focus is pulmonary and sleep medicine, with a patient-facing, service-centric business model—not a drug or device developer. Their founder, Robin Contino, is a prominent figure, and their mobile clinic approach uses industry-leading technologies (notably ndd Medical’s EasyOne Pro), facilitating respiratory diagnostics for underserved populations in California, North Carolina, and potentially Arizona.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Respiratory Labs.